[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356525-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356525-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","thoc3-interacts-with-epithelial-to-mesenchymal-transition-to-promote-non-small-cell-lung-cancer-carcinoma-progression-through-stat3-signaling-pathway-translational-oncology-67-102741","THOC3 interacts with epithelial-to-mesenchymal transition to promote non-small cell lung cancer carcinoma progression through STAT3 signaling pathway - Translational Oncology 67 102741","","Elevated THOC3 expression is observed in non-small cell lung cancer (NSCLC) and is associated with advanced tumor stages and poorer patient prognosis. Loss- and gain-of-function experiments indicate that THOC3 modulates proliferation, tumorigenic potential, and apoptosis in NSCLC models, with mechanistic involvement of the STAT3 pathway. Garcinone D-induced STAT3 activation enhances malignant features, while THOC3 silencing reverses these effects. These findings support THOC3 as a potential prognostic biomarker and therapeutic target in lung cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/thoc3-interacts-with-epithelial-to-mesenchymal-transition-to-promote-non-small-cell-lung-cancer-carcinoma-progression-through-stat3-signaling-pathway-translational-oncology-67-102741/356525/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/thoc3-interacts-with-epithelial-to-mesenchymal-transition-to-promote-non-small-cell-lung-cancer-carcinoma-progression-through-stat3-signaling-pathway-translational-oncology-67-102741/356525.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is THOC3’s clinical association in lung cancer?","Question",{"text":63,"@type":64},"THOC3 is elevated in lung cancer based on IHC analyses, with higher levels linked to advanced tumor stages and worse prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does THOC3 affect NSCLC cell behavior?",{"text":68,"@type":64},"Functional loss- and gain-of-function studies suggest THOC3 influences NSCLC proliferation, tumorigenic potential, and apoptosis in vitro.",{"name":70,"@type":61,"acceptedAnswer":71},"How is STAT3 signaling connected to THOC3 in this study?",{"text":72,"@type":64},"Mechanistic results indicate THOC3 effects involve activation of the STAT3 pathway, and STAT3 activation by Garcinone D mitigates malignant characteristics when THOC3 is silenced.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356525,1790215916,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Translational Oncology 67 (2026) 102741  \nContents lists available at ScienceDirect  \nTranslational Oncology  \njournal [homepage:](homepage: www.elsevier.com/locate/tranon)[ www.elsevier.com/locate/tranon](homepage: www.elsevier.com/locate/tranon)  \n| Original Research\u003Cbr>THOC3 interacts with epithelial-to-mesenchymal transition to promote non-small cell lung cancer carcinoma progression through STAT3 signaling pathway\u003Cbr>Zhengzheng Nia,1, Sheng Zhou b,c,1, Yan Zhang a, Xinyang Wang d, Hui Yanga, Hanyu Zhou e,*, Zheng Tao a,* \u003Cbr>a Department of Thoracic Surgery, the First Affiliated Hospital of Wannan Medical College, Wannan Medical College, Wuhu, China b Department of Respiratory and Critical Care Medicine,the Second People's Hospital of Changzhou, Changzhou, China\u003Cbr>c Department of Respiratory and Critical Care Medicine, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, China d Jining Medical University, Jining, China\u003Cbr>e Central Laboratory, the First Affiliated Hospital of Wannan Medical College, Wuhu, China |  |  |\n| --- | --- | --- |\n| A R T I C L E | I N F O | A B S T R A C T |\n| Keywords: THOC3 STAT3\u003Cbr>EMT Biomarker Lung cancer |  | Located on chromosome 5, the THOC3 gene encodes a protein of 351 amino acids, though its precise biological role in various malignancies, including lung cancer (LC), remains to be fully clarified. Elevated expression of THOC3 was observed in LC (IHC) analyses. Increased THOC3 levels were associated with advanced tumor stages and poorer prognosis in patients. Functional studies using both loss-of-function and gain-of-function approaches suggested that THOC3 may influence cellular proliferation, tumorigenic potential, and apoptosis in vitro. Mechanistically, its effects appear to involve activation of the STAT3 pathway. Additionally, Garcinone Dinduced STAT3 activation mitigated certain malignant characteristics of LC cells, though silencing THOC3 reversed this effect. These results indicate that THOC3 may serve as a potential prognostic marker and could warrant further investigation as a therapeutic target in LC. |\n\nIntroduction  \nLung cancer (LC) has remained the leading cause of cancer-related mortality worldwide since the mid-1900s, posing an ongoing public health challenge due to persistently high incidence and mortality rates [1]. Approximately 85% of LC cases are classified as non-small cell lung carcinoma (NSCLC), a subtype historically linked to poor survival outcomes, primarily due to late-stage diagnosis and limited therapeutic options [2]. Tumor progression and metastasis are significantly influenced by epithelial-to-mesenchymal transition (EMT), a cellular process associated with worse prognosis. Extensive evidence has shown that EMT not only enhances cancer cell motility and metastatic potential but also improves cellular survival, highlighting the need for targeting EMT pathways to enhance patient outcomes [3–6].  \nRecent studies have highlighted the crucial role of mRNA nuclear export in tumor initiation and malignant progression across various cancer types [7]. As a key regulatory mechanism for eukaryotic cell  \ngrowth, mRNA export significantly affects gene expression [8]. Integral to this process is the transcription-export (TREX) complex, within which the THO complex (THOC) plays a crucial role in mRNA splicing, transcript elongation of during transcription, and nuclear export of newly synthesized RNA molecules. In mammals, the THOC machinery consists of six specific protein: THOC1, THOC2, THOC3, THOC5, THOC6, and THOC7.  \nDysregulation of THOC proteins disrupts the quality control of nuclear mRNA export, compromising transcriptional accuracy. Genetic loss of THOC family components leads to transcriptional instability and increased genomic aberrations. Growing evidence suggests that several THOC members significantly contribute to oncogenic progression in a variety of cancers [9,10]. For example, overexpression of THOC1 has been linked to increased","cbCaiedr66nKYqFV","https://ap.wps.com/l/cbCaiedr66nKYqFV","pdf",5379940,"English","# Introduction\n## Lung cancer burden and NSCLC context\n## EMT in tumor progression and prognosis\n## mRNA nuclear export, TREX complex, and THOC proteins\n# Results\n## THOC3 expression in NSCLC and clinical correlation\n## THOC3 functional effects on NSCLC cell phenotypes\n## STAT3 pathway involvement and Garcinone D intervention\n# Discussion\n## THOC3 as prognostic marker and therapeutic target","[{\"question\":\"What is THOC3’s clinical association in lung cancer?\",\"answer\":\"THOC3 is elevated in lung cancer based on IHC analyses, with higher levels linked to advanced tumor stages and worse prognosis.\"},{\"question\":\"How does THOC3 affect NSCLC cell behavior?\",\"answer\":\"Functional loss- and gain-of-function studies suggest THOC3 influences NSCLC proliferation, tumorigenic potential, and apoptosis in vitro.\"},{\"question\":\"How is STAT3 signaling connected to THOC3 in this study?\",\"answer\":\"Mechanistic results indicate THOC3 effects involve activation of the STAT3 pathway, and STAT3 activation by Garcinone D mitigates malignant characteristics when THOC3 is silenced.\"}]","THOC3 interacts with epithelial-to-mesenchymal transition to promote non-small cell lung cancer carcinoma progression through STAT3 signaling pathway - Translational Oncology 67 102741 | PDF",1790125812,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b678a0d884f5049fcb24c00f08a988d3.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7c3ddb9d6ada51a40a1e954ed36a724.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f427e617c3a32e48fc7c58cca49f70b4.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/329be79ae79287211a5ba35485c978aa.webp",980,1306]